These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29336832)

  • 1. Anticoagulation in neonatal ECMO.
    Kamdar A; Rintoul N; Raffini L
    Semin Perinatol; 2018 Mar; 42(2):122-128. PubMed ID: 29336832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation during ECMO in neonatal and paediatric patients.
    Barton R; Ignjatovic V; Monagle P
    Thromb Res; 2019 Jan; 173():172-177. PubMed ID: 29779622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
    Fitousis K; Klasek R; Mason PE; Masud F
    Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation.
    Saini A; Spinella PC
    Clin Lab Med; 2014 Sep; 34(3):655-73. PubMed ID: 25168949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and coagulation management for ECMO.
    Oliver WC
    Semin Cardiothorac Vasc Anesth; 2009 Sep; 13(3):154-75. PubMed ID: 19767408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
    Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
    Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation Laboratories.
    Winkler AM
    Semin Thromb Hemost; 2017 Apr; 43(3):291-299. PubMed ID: 28166602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support Organization.
    Van Edom CJ; Swol J; Castelein T; Gramegna M; Huber K; Leonardi S; Mueller T; Pappalardo F; Price S; Schaubroeck H; Schrage B; Tavazzi G; Vercaemst L; Vranckx P; Vandenbriele C
    Eur Heart J Acute Cardiovasc Care; 2024 Jun; 13(6):458-469. PubMed ID: 38529950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.
    Tang S; Xu L; Li H; Wu Z; Wen Q
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1583-1594. PubMed ID: 37740749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation.
    Niebler RA; Parker H; Hoffman GM
    ASAIO J; 2019; 65(3):270-276. PubMed ID: 29746314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO.
    Chlebowski MM; Baltagi S; Carlson M; Levy JH; Spinella PC
    Crit Care; 2020 Jan; 24(1):19. PubMed ID: 31959232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges with Navigating the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation and Transfusion Management.
    Andrews J; Winkler AM
    Transfus Med Rev; 2016 Oct; 30(4):223-9. PubMed ID: 27543261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation strategies and difficulties in neonatal and paediatric extracorporeal membrane oxygenation (ECMO).
    Stocker CF; Horton SB
    Perfusion; 2016 Mar; 31(2):95-102. PubMed ID: 26060200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.